Global Vigilance/Safety Policy
This is to present the Policy for Safety Management of the medicinal products, devices and related products (hereinafter referred to as "products") of Mitsubishi Tanabe Pharma Group (MTPC Group). This policy is applicable to all staff involved in the safety management activities for all MTPC Group's products.
- 1MTPC Group will strive to ensure the safety of all patients, implement effective post-marketing vigilance and risk minimization and promote and encourage proper use of our products throughout their lifecycles. By doing this, MTPC Group will also provide patients with reassurance and gain trust from the healthcare professionals.
- 2At all times MTPC Group will act in an ethical manner and comply fully with all relevant laws, regulations and guidelines, to ensure compliant and effective safety management of our products.
- 3MTPC Group will develop the safety management system based on the global standard operating procedures. MTPC Group will employ and retain the required safety staff and provide them with the necessary education and training, to ensure provision of the highest quality of safety information.
Mitsubishi Tanabe Pharma Corporation will structure and maintain the appropriate Global Safety Headquarters and associated operations to deliver these activities.